Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 80 Pages
Report ld: 5581291
Request Sample
Customized Report
Knee Denervation Market Size(US$)

CAGR 2026-2032
20.3%
Market Size,2032
USD 1,482
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Knee Denervation market size was US$ 413 million in 2025 and is forecast to reach a readjusted size of US$ 1482 million by 2032 with a CAGR of 20.3% during the forecast period 2026-2032.
Knee denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.
Osteoarthritis (OA) is a degenerative disease common in synovial joints, which can cause degeneration of articular cartilage, bone hyperplasia at the joint margin and under the cartilage, etc. Knee osteoarthritis (KOA) is the most common knee disease in the limb joints. Domestic statistics show that more than 3% of people in my country suffer from OA, and KOA accounts for the majority. As my country gradually enters an aging society, the incidence of KOA is higher in the population. According to relevant data, the incidence rate in people over 60 years old is as high as 12%, and it is increasing with age.
KOA is essentially a degenerative disease and cannot be cured clinically. At present, KOA patients mostly use conservative treatments such as physical therapy, analgesics and intra-articular injections to control pain and improve their quality of life. Before drug intervention, there are auxiliary treatment measures such as physical therapy, exercise, and weight loss. It is generally believed that anti-inflammatory analgesics are the first choice for the treatment of KOA, but long-term use often produces adverse reactions. Intra-articular injection of glucocorticoids or sodium hyaluronate is believed to relieve inflammation in the joint and promote cartilage repair. Repeated injections can maintain the efficacy, but the effect will still decline after several years. Total knee arthroplasty (TKA) surgery is considered to be the only effective ultimate solution, but some patients still have poor postoperative effects or long-term postoperative pain. The urgent need for pain treatment in KOA patients has given rise to the application of Knee Denervation technology in this field.
Knee Denervation includes traditional radiofrequency ablation (RFA), pulsed radiofrequency (PRF), cooled RFA (CRF) and laser treatment. The principles, parameters and efficacy of Knee Denervation technology are still in the early stages, which leads to large differences in the technical methods used by different research teams. However, through a systematic evaluation of numerous clinical trials and case reports, it can still be concluded that Knee Denervation can relieve pain and improve quality of life for up to about 1 year in the treatment of postoperative pain after KOA or TKA, and has the advantages of less trauma and fewer complications.
According to our data, the global volume of Knee Denervation surgeries will be around 130,000 in 2024, and the volume is expected to reach 155,000 in 2025. The compound annual growth rate of Knee Denervation will reach more than 15% in the next five years, and the market size will exceed US$100 million by 2030. From a regional perspective, North America occupies a major position in the Knee Denervation industry with its complete medical facilities and advanced technology, with a market share of nearly 50% in 2024, followed by Europe and Asia Pacific. From a technical point of view, the main method of Knee Denervation is radiofrequency ablation, which will account for more than 90% in 2024, but laser therapy (invasive LA) and other methods are gradually showing their advantages and are developing rapidly.
With the extension of life expectancy, the health problems caused by degenerative diseases will inevitably become a major health threat. The knee joint is an important load-bearing joint in the human body. Chronic pain, especially KOA, will seriously reduce the quality of life of patients. Patients with moderate to severe or refractory KOA benefit less from traditional treatments and have to endure many adverse reactions. TKA surgery can only solve the problems of some patients. Some patients still have poor surgical results or do not have the conditions for surgical treatment. Knee Denervation for pain treatment has shown good therapeutic effects and high safety, and has huge market potential in the future.
The global Knee Denervation market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Knee Denervation sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Knee Denervation manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Knee Denervation product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Knee Denervation value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Knee Denervation Product Scope
1.2 Knee Denervation by Type
1.2.1 Global Knee Denervation Sales by Type (2021, 2025 & 2032)
1.2.2 Standard RFA
1.2.3 Cooled RFA
1.2.4 Others
1.3 Knee Denervation by Application
1.3.1 Global Knee Denervation Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Knee Denervation Market Estimates and Forecasts (2021-2032)
1.4.1 Global Knee Denervation Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Knee Denervation Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Knee Denervation Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Knee Denervation Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Knee Denervation Historical Market Scenario by Region (2021-2026)
2.2.1 Global Knee Denervation Sales Market Share by Region (2021-2026)
2.2.2 Global Knee Denervation Revenue Market Share by Region (2021-2026)
2.3 Global Knee Denervation Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Knee Denervation Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Knee Denervation Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Knee Denervation Market Size and Prospects (2021-2032)
2.4.2 Europe Knee Denervation Market Size and Prospects (2021-2032)
2.4.3 China Knee Denervation Market Size and Prospects (2021-2032)
2.4.4 Japan Knee Denervation Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Knee Denervation Historical Market Review by Type (2021-2026)
3.1.1 Global Knee Denervation Sales by Type (2021-2026)
3.1.2 Global Knee Denervation Revenue by Type (2021-2026)
3.1.3 Global Knee Denervation Average Price by Type (2021-2026)
3.2 Global Knee Denervation Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Knee Denervation Sales Forecast by Type (2027-2032)
3.2.2 Global Knee Denervation Revenue Forecast by Type (2027-2032)
3.2.3 Global Knee Denervation Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Knee Denervation
4 Global Market Size by Application
4.1 Global Knee Denervation Historical Market Review by Application (2021-2026)
4.1.1 Global Knee Denervation Sales by Application (2021-2026)
4.1.2 Global Knee Denervation Revenue by Application (2021-2026)
4.1.3 Global Knee Denervation Average Price by Application (2021-2026)
4.2 Global Knee Denervation Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Knee Denervation Sales Forecast by Application (2027-2032)
4.2.2 Global Knee Denervation Revenue Forecast by Application (2027-2032)
4.2.3 Global Knee Denervation Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Knee Denervation Applications
5 Competition Landscape by Players
5.1 Global Knee Denervation Sales by Player (2021-2026)
5.2 Global Top Knee Denervation Players by Revenue (2021-2026)
5.3 Global Knee Denervation Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Knee Denervation revenue as of 2025
5.4 Global Knee Denervation Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Knee Denervation, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Knee Denervation, Product Type & Application
5.7 Global Key Manufacturers of Knee Denervation, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Knee Denervation Sales by Company
6.1.1.1 North America Knee Denervation Sales by Company (2021-2026)
6.1.1.2 North America Knee Denervation Revenue by Company (2021-2026)
6.1.2 North America Knee Denervation Sales Breakdown by Type (2021-2026)
6.1.3 North America Knee Denervation Sales Breakdown by Application (2021-2026)
6.1.4 North America Knee Denervation Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Knee Denervation Sales by Company
6.2.1.1 Europe Knee Denervation Sales by Company (2021-2026)
6.2.1.2 Europe Knee Denervation Revenue by Company (2021-2026)
6.2.2 Europe Knee Denervation Sales Breakdown by Type (2021-2026)
6.2.3 Europe Knee Denervation Sales Breakdown by Application (2021-2026)
6.2.4 Europe Knee Denervation Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Knee Denervation Sales by Company
6.3.1.1 China Knee Denervation Sales by Company (2021-2026)
6.3.1.2 China Knee Denervation Revenue by Company (2021-2026)
6.3.2 China Knee Denervation Sales Breakdown by Type (2021-2026)
6.3.3 China Knee Denervation Sales Breakdown by Application (2021-2026)
6.3.4 China Knee Denervation Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Knee Denervation Sales by Company
6.4.1.1 Japan Knee Denervation Sales by Company (2021-2026)
6.4.1.2 Japan Knee Denervation Revenue by Company (2021-2026)
6.4.2 Japan Knee Denervation Sales Breakdown by Type (2021-2026)
6.4.3 Japan Knee Denervation Sales Breakdown by Application (2021-2026)
6.4.4 Japan Knee Denervation Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Business Overview
7.1.3 Boston Scientific Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Boston Scientific Knee Denervation Products Offered
7.1.5 Boston Scientific Recent Development
7.2 Stryker
7.2.1 Stryker Company Information
7.2.2 Stryker Business Overview
7.2.3 Stryker Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Stryker Knee Denervation Products Offered
7.2.5 Stryker Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Business Overview
7.3.3 Abbott Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Abbott Knee Denervation Products Offered
7.3.5 Abbott Recent Development
7.4 Avanos Medical (coolief)
7.4.1 Avanos Medical (coolief) Company Information
7.4.2 Avanos Medical (coolief) Business Overview
7.4.3 Avanos Medical (coolief) Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Avanos Medical (coolief) Knee Denervation Products Offered
7.4.5 Avanos Medical (coolief) Recent Development
7.5 Cosman Medical
7.5.1 Cosman Medical Company Information
7.5.2 Cosman Medical Business Overview
7.5.3 Cosman Medical Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Cosman Medical Knee Denervation Products Offered
7.5.5 Cosman Medical Recent Development
7.6 Diros Technology
7.6.1 Diros Technology Company Information
7.6.2 Diros Technology Business Overview
7.6.3 Diros Technology Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Diros Technology Knee Denervation Products Offered
7.6.5 Diros Technology Recent Development
7.7 Vantage MedTech
7.7.1 Vantage MedTech Company Information
7.7.2 Vantage MedTech Business Overview
7.7.3 Vantage MedTech Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Vantage MedTech Knee Denervation Products Offered
7.7.5 Vantage MedTech Recent Development
7.8 STARmed America
7.8.1 STARmed America Company Information
7.8.2 STARmed America Business Overview
7.8.3 STARmed America Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.8.4 STARmed America Knee Denervation Products Offered
7.8.5 STARmed America Recent Development
7.9 Beijing Neo Science
7.9.1 Beijing Neo Science Company Information
7.9.2 Beijing Neo Science Business Overview
7.9.3 Beijing Neo Science Knee Denervation Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Beijing Neo Science Knee Denervation Products Offered
7.9.5 Beijing Neo Science Recent Development
8 Knee Denervation Manufacturing Cost Analysis
8.1 Knee Denervation Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Knee Denervation
8.4 Knee Denervation Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Knee Denervation Distributors List
9.3 Knee Denervation Customers
10 Knee Denervation Market Dynamics
10.1 Knee Denervation Industry Trends
10.2 Knee Denervation Market Drivers
10.3 Knee Denervation Market Challenges
10.4 Knee Denervation Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Knee Denervation market was valued at US$ 413 million in 2025 and is anticipated to reach US$ 1482 million by 2032, at a CAGR of 20.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 117
USD 2900.00
(Single User License)
The global market for Knee Denervation was estimated to be worth US$ 413 million in 2025 and is projected to reach US$ 1482 million, growing at a CAGR of 20.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 104
USD 3950.00
(Single User License)
The global Knee Denervation market size was US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published Date: 2025-09-11
Pages: 76
USD 4250.00
(Single User License)
The global Knee Denervation market is projected to grow from US$ 354 million in 2024 to US$ 1253 million by 2031, at a CAGR of 20.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-30
Pages: 137
USD 4900.00
(Single User License)
The global Knee Denervation market is projected to grow from US$ 413 million in 2025 to US$ 1253 million by 2031, at a Compound Annual Growth Rate (CAGR) of 20.3% during the forecast period.
Published Date: 2025-06-26
Pages: 129
USD 4900.00
(Single User License)
The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published Date: 2025-06-26
Pages: 103
USD 3950.00
(Single User License)
The global market for Knee Denervation was valued at US$ 354 million in the year 2024 and is projected to reach a revised size of US$ 1253 million by 2031, growing at a CAGR of 20.3% during the forecast period.
Published Date: 2025-06-26
Pages: 79
USD 2900.00
(Single User License)
The global market for Knee Denervation was valued at US$ 309 million in the year 2023 and is projected to reach a revised size of US$ 1076 million by 2030, growing at a CAGR of 20.3% during the forecast period.
Published Date: 2024-12-29
Pages: 79
USD 2900.00
(Single User License)
The global market for Knee Denervation was estimated to be worth US$ 309 million in 2023 and is forecast to a readjusted size of US$ 1076 million by 2030 with a CAGR of 20.3% during the forecast period 2024-2030.
Published Date: 2024-12-29
Pages: 104
USD 3950.00
(Single User License)
Valued at US$ 355 million in 2024, the global Knee Denervation market is forecast to reach US$ 1076 million by 2030, at a CAGR of 20.3% during the forecast period.
Published Date: 2024-12-29
Pages: 127
USD 4900.00
(Single User License)
The global Knee Denervation market was valued at US$ 413 million in 2025 and is anticipated to reach US$ 1482 million by 2032, at a CAGR of 20.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 117
The global market for Knee Denervation was estimated to be worth US$ 413 million in 2025 and is projected to reach US$ 1482 million, growing at a CAGR of 20.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 104
The global Knee Denervation market size was US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published: 2025-09-11
Pages: 76
The global Knee Denervation market is projected to grow from US$ 354 million in 2024 to US$ 1253 million by 2031, at a CAGR of 20.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-30
Pages: 137
The global Knee Denervation market is projected to grow from US$ 413 million in 2025 to US$ 1253 million by 2031, at a Compound Annual Growth Rate (CAGR) of 20.3% during the forecast period.
Published: 2025-06-26
Pages: 129
The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 103
The global market for Knee Denervation was valued at US$ 354 million in the year 2024 and is projected to reach a revised size of US$ 1253 million by 2031, growing at a CAGR of 20.3% during the forecast period.
Published: 2025-06-26
Pages: 79
The global market for Knee Denervation was valued at US$ 309 million in the year 2023 and is projected to reach a revised size of US$ 1076 million by 2030, growing at a CAGR of 20.3% during the forecast period.
Published: 2024-12-29
Pages: 79
The global market for Knee Denervation was estimated to be worth US$ 309 million in 2023 and is forecast to a readjusted size of US$ 1076 million by 2030 with a CAGR of 20.3% during the forecast period 2024-2030.
Published: 2024-12-29
Pages: 104
Valued at US$ 355 million in 2024, the global Knee Denervation market is forecast to reach US$ 1076 million by 2030, at a CAGR of 20.3% during the forecast period.
Published: 2024-12-29
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now